- Home
- ABUS vs MLAB Comparison
ABUS vs MLAB Comparison
Compare ABUS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- MLAB
- Stock Information
- Founded
- ABUS 2005
- MLAB 1982
- Country
- ABUS United States
- MLAB United States
- Employees
- ABUS N/A
- MLAB N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- ABUS Health Care
- MLAB Industrials
- Exchange
- ABUS Nasdaq
- MLAB Nasdaq
- Market Cap
- ABUS 592.8M
- MLAB 680.0M
- IPO Year
- ABUS N/A
- MLAB N/A
- Fundamental
- Price
- ABUS $3.24
- MLAB $114.52
- Analyst Decision
- ABUS Strong Buy
- MLAB Hold
- Analyst Count
- ABUS 4
- MLAB 2
- Target Price
- ABUS $5.50
- MLAB $140.00
- AVG Volume (30 Days)
- ABUS 1.3M
- MLAB 57.0K
- Earning Date
- ABUS 05-05-2025
- MLAB 05-30-2025
- Dividend Yield
- ABUS N/A
- MLAB 0.55%
- EPS Growth
- ABUS N/A
- MLAB N/A
- EPS
- ABUS N/A
- MLAB N/A
- Revenue
- ABUS $6,171,000.00
- MLAB $237,747,000.00
- Revenue This Year
- ABUS $14.57
- MLAB $13.48
- Revenue Next Year
- ABUS $15.84
- MLAB $4.74
- P/E Ratio
- ABUS N/A
- MLAB N/A
- Revenue Growth
- ABUS N/A
- MLAB 11.68
- 52 Week Low
- ABUS $2.63
- MLAB $83.68
- 52 Week High
- ABUS $4.72
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- ABUS 50.09
- MLAB 46.39
- Support Level
- ABUS $2.71
- MLAB $108.32
- Resistance Level
- ABUS $3.32
- MLAB $117.85
- Average True Range (ATR)
- ABUS 0.21
- MLAB 8.01
- MACD
- ABUS 0.00
- MLAB 0.82
- Stochastic Oscillator
- ABUS 63.86
- MLAB 73.23
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.